Zydus Lifesciences Ltd. (ZYDUSLIFE) - Financials, balance sheet (annual)

903.5 INR

1.65

0.18%

Last update May 14, 3:29 PM IST

Main market

Day range

903.5

890.54999

909.5

Previous close

901.84998

Open

903.45001

Access this stock data via API

Zydus Lifesciences Ltd.

903.50

1.65

0.18%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	292.8B	257.6B	278.0B	238.8B
Current assets	115.0B	100.2B	122.6B	87.2B
Cash	4.1B	4.9B	6.6B	6.7B
Cash equivalents	—	—	—	—
Cash and cash equivalents	4.1B	4.9B	6.6B	6.7B
Other short term investments	9.7B	7.2B	28.2B	4.6B
Accounts receivable	52.2B	44.2B	33.4B	31.3B
Other receivables	2.7B	1.5B	1.5B	1.7B
Inventory	34.4B	34.1B	37.2B	32.4B
Prepaid assets	7.2B	7.3B	13.2B	9.1B
Restricted cash	46M	48M	54M	—
Assets held for sale	816M	82M	1.7B	0
Hedging assets	2.8B	0	—	—
Other current assets	175M	186M	48M	28M
Non current assets	177.8B	157.4B	155.3B	151.7B
Properties	58.0B	57.0B	57.6B	55.5B
Land and improvements	6.2B	6.3B	5.7B	5.7B
Machinery furniture equipment	80.8B	75.0B	71.3B	65.6B
Construction in progress	11.1B	11.3B	6.6B	7.8B
Leases	—	—	—	—
Accumulated depreciation	-50.8B	-45.0B	-39.1B	-36.3B
Goodwill	131.4B	107.0B	118.6B	119.3B
Investment properties	—	—	—	—
Financial assets	0	1.8B	1.7B	1.6B
Intangible assets	26.1B	10.9B	11.3B	12.4B
Investments and advances	—	—	—	—
Other non current assets	210M	181M	144M	93M
Total liabilities	71.8B	60.7B	87.4B	89.6B
Current liabilities	53.4B	55.3B	78.4B	78.6B
Accounts payable	21.3B	21.3B	21.4B	22.1B
Accrued expenses	—	—	—	—
Short term debt	7.8B	11.8B	38.4B	39.8B
Deferred revenue	—	—	—	—
Tax payable	3.7B	1.6B	418M	884M
Pensions	—	—	—	—
Other current liabilities	396M	510M	345M	241M
Non current liabilities	18.4B	5.4B	9.0B	10.9B
Long term provisions	3.1B	2.7B	3.3B	3.1B
Long term debt	251M	198M	3.8B	6.2B
Provision for risks and charges	—	—	—	—
Deferred liabilities	4.5B	1.9B	1.5B	1.2B
Derivative product liabilities	—	—	—	—
Other non current liabilities	18M	—	3M	10M
Shareholders equity
Common stock	1.0B	1.0B	1.0B	1.0B
Retained earnings	203.7B	171.9B	155.0B	113.8B
Other shareholders equity	—	—	—	—
Total shareholders equity	221.0B	196.9B	190.5B	149.3B
Additional paid in capital	18M	12M	0	—
Treasury stock	—	—	—	—
Minority interest	22.7B	21.7B	20.5B	19.4B